BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 27828769)

  • 1. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Kori M; Aydın B; Unal S; Arga KY; Kazan D
    OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.
    Shvetcov A; Thomson S; Spathos J; Cho AN; Wilkins HM; Andrews SJ; Delerue F; Couttas TA; Issar JK; Isik F; Kaur S; Drummond E; Dobson-Stone C; Duffy SL; Rogers NM; Catchpoole D; Gold WA; Swerdlow RH; Brown DA; Finney CA
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.
    Garofalo M; Pandini C; Bordoni M; Pansarasa O; Rey F; Costa A; Minafra B; Diamanti L; Zucca S; Carelli S; Cereda C; Gagliardi S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Bioenergetics in Neurodegeneration.
    Strope TA; Birky CJ; Wilkins HM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
    Front Immunol; 2018; 9():2122. PubMed ID: 30283455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Di Matteo V; Esposito E
    Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Managing Neurodegenerative Diseases.
    Cheslow L; Snook AE; Waldman SA
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.
    Wuolikainen A; Jonsson P; Ahnlund M; Antti H; Marklund SL; Moritz T; Forsgren L; Andersen PM; Trupp M
    Mol Biosyst; 2016 Apr; 12(4):1287-98. PubMed ID: 26883206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COX plays a pivotal role in the progressive neuronal loss in neurodegenerative diseases].
    Gao JP; Sun S; Li WW; Zhao H; Cai DF
    Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):214-20. PubMed ID: 18819488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene networks in neurodegenerative disorders.
    Recabarren D; Alarcón M
    Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson's, Alzheimer's and ALS disease.
    Patel R; Brophy C; Hickling M; Neve J; Furger A
    BMC Med Genomics; 2019 May; 12(1):60. PubMed ID: 31072331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Barc K; Kuźma-Kozakiewicz M
    Neurol Neurochir Pol; 2019; 53(2):99-112. PubMed ID: 30855701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.